Status:
COMPLETED
OFDI-Quantified Intracoronary Thrombus, Antiplatelet Pretreatment Effect and Myocardial Reperfusion
Lead Sponsor:
University Hospital, Caen
Conditions:
Myocardial Infarction
Thrombosis, Coronary
Eligibility:
All Genders
18+ years
Brief Summary
The management of ST-elevation myocardial infarction in the acute phase requires an optimal antiaggregation combining aspirin and a P2Y12 inhibitor (clopidogrel, prasugrel or ticagrelor). Primary perc...
Eligibility Criteria
Inclusion
- primary PCI with successful stenting for ST-elevation myocardial infarction
- pretreated with ticagrelor, aspirin and enoxaparin
- OCT and verifyNow performed in the acute phase
Exclusion
- stent thrombosis
- known coagulation disorder
- clinical instability
- pregnancy
Key Trial Info
Start Date :
October 13 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT03342521
Start Date
October 13 2017
End Date
December 31 2018
Last Update
April 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CAEN University Hospital
Caen, France, 14000